Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2003
05/20/2003US6565850 Hemorrhoidal compositions and method of use
05/20/2003US6565843 Protein-induced tissue morphogenesis
05/20/2003US6565842 Crosslinking gel
05/20/2003US6565841 Pulmonary administration of granulocyte colony stimulating factor
05/20/2003CA2262001C Mhc binding peptide oligomers and methods of use
05/20/2003CA2215534C Stable protein: phospholipid compositions and methods
05/20/2003CA2131551C Conjugates formed from heat shock proteins and oligo- or polysaccharides
05/20/2003CA2084194C Oral delivery systems for microparticles
05/20/2003CA2046014C Reduction or prevention of skin irritation by drugs
05/16/2003CA2411889A1 Films containing starch
05/15/2003WO2003040693A2 Peptides that home to tumor lymphatic vasculature and methods of using same
05/15/2003WO2003040686A2 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
05/15/2003WO2003040398A2 Proteins stabilized with polysaccharide gums
05/15/2003WO2003040375A1 COMPOSITIONS AND PROCESSES USING siRNA, AMPHIPATHIC COMPOUNDS AND POLYCATIONS
05/15/2003WO2003040365A2 Pna-conjugate or pna-conjugate mixture for treating diseases related to the human papillomavirus
05/15/2003WO2003040287A2 Isotope-coded affinity tag
05/15/2003WO2003040235A1 Synthetic matrix for controlled cell ingrowth and tissue regeneration
05/15/2003WO2003040215A1 Biodegradable copolymers
05/15/2003WO2003040211A2 Branched polymers and their conjugates
05/15/2003WO2003040175A1 Conjugate for treating by boron neutron capture (bnc) radiation-resistant tumours
05/15/2003WO2003040169A2 Human monoclonal antibodies to dendritic cells
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003040138A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040137A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040136A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040104A1 Dimeric pharmaceutical compounds and their use
05/15/2003WO2003040093A2 Isotopically coded affinity marker 2
05/15/2003WO2003040073A1 Alkyl(en)ylglycerinether carboxylic acids
05/15/2003WO2003039616A1 Percutaneous transluminal drug delivery device
05/15/2003WO2003039600A1 Selective treatment of il-13 expressing tumors
05/15/2003WO2003039597A1 Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
05/15/2003WO2003039596A1 Photodynamic therapy for the treatment of hair loss
05/15/2003WO2003039595A2 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
05/15/2003WO2003039577A1 Remedies for dry eye and diseases associated with dry eye
05/15/2003WO2003039564A1 Selective targeting of apoptotic cells
05/15/2003WO2003039532A1 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
05/15/2003WO2003039531A1 Modified release tamsulosin tablets
05/15/2003WO2003039530A1 Tamsulosin tablets
05/15/2003WO2003039522A1 Surface coated capsules
05/15/2003WO2003039521A1 Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs
05/15/2003WO2003039520A1 Orodispersible tablet having high homogeneity and the preparation method thereof
05/15/2003WO2003039518A1 Oral controlled release forms useful for reducing or preventing nicotine cravings
05/15/2003WO2003039517A1 Process for preparing quick dissolving, high loading ribavirin compositions
05/15/2003WO2003039516A1 Method for improving dissolution of poorly dispersible medicaments
05/15/2003WO2003039515A1 Process for preparing dry extracts
05/15/2003WO2003039514A1 Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
05/15/2003WO2003039511A1 New use of ethoxylated phytosterols and phytostanols
05/15/2003WO2003039510A1 Compositions containing oils having a specific gravity higher than the specific gravity of water
05/15/2003WO2003039504A1 Solid oral compositions
05/15/2003WO2003039485A2 Stable liquid pharmaceutical formulation of igg antibodies
05/15/2003WO2003039479A2 Polymeric thiol-linked prodrugs
05/15/2003WO2003039472A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003WO2003039465A2 Treating canker sores with patches to speed healing and relieve pain
05/15/2003WO2003039452A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003WO2003039444A2 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
05/15/2003WO2003039437A2 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
05/15/2003WO2003039435A2 Process of obtaining colloidal dispersions of amphotercin b; compounds based on amphothericine b for enteral, paraenteral and topical use; use of these compounds in the treatment of systemic mycoses and parasitic infections
05/15/2003WO2003039434A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof
05/15/2003WO2003039382A2 System for processing tissue
05/15/2003WO2003039331A2 Method for improving stability of a bone-connecting implant
05/15/2003WO2003039273A1 Molecular press dehydration method for vegetative tissue using the solid phase of water soluble polymer substances as a dehydrating agent
05/15/2003WO2003039225A2 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003WO2003006063A3 Formulation comprising fulvestrant
05/15/2003WO2002102169A3 Synthetic fat composition
05/15/2003WO2002094316A3 Method of preparing aluminium-hydroxide gel
05/15/2003WO2002088318A3 Lipid-comprising drug delivery complexes and methods for their production
05/15/2003WO2002083179A3 Fusion proteins
05/15/2003WO2002055108A9 Targeted modification of intracellular compounds
05/15/2003WO2002049620A3 Induced phase transition method for the production of microparticles containing hydrophobic active agents
05/15/2003WO2002038208A3 Device and method for the cessation of smoking
05/15/2003WO2002017888A9 Controlled and sustained release properties of polyelectrolyte multilayer capsules
05/15/2003WO2001080832A3 Administration of a thiol-based chemoprotectant compound
05/15/2003WO2001022791A8 Controlled release compositions comprising nimesulide
05/15/2003US20030093157 Biocompatible,bulking agent or implant that degrades slowly under biological conditions, is hypoallergenic, non-migratory, relatively inexpensive and simple to apply; for therapy of congenital anomaly, a scar or a wrinkle
05/15/2003US20030093092 Optically-absorbing nanoparticles for enhanced tissue repair
05/15/2003US20030092901 Preparation of oligonucleotide-protein conjugate; obtain oligonucleotide expose to linker, join, expose oligonucleotide-linker conjugate with preferential protein, join, recover oligonucleotide-protein conjugate
05/15/2003US20030092894 Conjugated antigen for use as tool in the treatment of cancer
05/15/2003US20030092800 Sustained release; drug delivery
05/15/2003US20030092776 Drug mixed with polymeric carrier; bioavailability; ethylene oxide-propylene oxide copolymer; film forming
05/15/2003US20030092764 Oxidation resistance
05/15/2003US20030092755 Novel prodrugs for antimicrobial amidines
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092688 Non-combustible water-dispersible vitamin compositions
05/15/2003US20030092672 Amphiphilic macrocyclic derivatives and their analogues
05/15/2003US20030092666 Compositions and methods for nucleic acid delivery to the lung
05/15/2003US20030092663 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092640 Water, azalide compound, 25-75% propylene glycol, and acids
05/15/2003US20030092630 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
05/15/2003US20030092622 Preparation stabilized over long time
05/15/2003US20030092612 Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
05/15/2003US20030092608 Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor
05/15/2003US20030092607 A stable antibody liquid comprising a precipitated immunoglobulins and water; precipitating with a biocompatible polymer; storage stability
05/15/2003US20030092606 Formulations for amylin agonist peptides
05/15/2003US20030092198 Site-specific labeling of disulfide-containing targeting vectors
05/15/2003US20030092180 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
05/15/2003US20030092163 Probiotic bifidobacterium strains
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092044 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders
05/15/2003US20030092029 Magneitc-nanoparticle conjugates and methods of use
1 ... 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 ... 1712